(Q53794423)
Statements
Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study. (English)
Jean-Yves Douillard
Jaafar Bennouna
Christophe Borg
Jean-Pierre Delord
Faress Husseini
Véronique Trillet-Lenoir
Roger Faroux
Eric François
Marc Ychou
François Goldwasser
Olivier Bouché
Helene Senellart
Sandrine Kraemer
29 July 2011
11
1
38-44